Amneal Pharmaceuticals, Inc.AMRXNASDAQ
Loading
Cash Generation ExpandingExpanding
Percentile Rank82
3Y CAGR+73.5%
5Y CAGR-2.1%
Year-over-Year Change
Cash generated from core business operations
3Y CAGR
+73.5%/yr
vs -28.6%/yr prior
5Y CAGR
-2.1%/yr
Recent acceleration
Acceleration
+102.1pp
Accelerating
Percentile
P82
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $339.99M | +15.2% |
| 2024 | $295.10M | -14.6% |
| 2023 | $345.58M | +430.8% |
| 2022 | $65.10M | -73.1% |
| 2021 | $241.82M | -36.2% |
| 2020 | $379.00M | +22128.8% |
| 2019 | $1.71M | -99.3% |
| 2018 | $250.23M | +6.9% |
| 2017 | $234.19M | +103.5% |
| 2016 | $115.06M | - |